Kevin Lee is Chief Executive Officer of Bicycle Therapeutics plc (BCYC). The company reported total compensation of $6,341,473 for fiscal year 2025.
| Salary | $862,339 |
|---|---|
| Bonus | $0 |
| Stock awards | $1,724,800 |
| Option awards | $2,961,297 |
| Non-equity incentive plan | $543,642 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $249,395 |
| Total | $6,341,473 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Bicycle Therapeutics plc filed April 22, 2026, accession 0001104659-26-046806.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Kevin Lee this page | Chief Executive Officer | $6,341,473 |
| Michael Skynner | Chief Technology Officer (2025); Chief Scientific Officer (effective January 1, 2026) | $2,327,010 |
| Alistair Milnes | Chief Operating Officer (2025); Chief Corporate Development Officer (effective March 17, 2026) | $2,292,424 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Bicycle Therapeutics plc compensation brief.
Kevin Lee's compensation sits inside Bicycle Therapeutics plc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.